Little is known about Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) rates in community-supervised juvenile justice-involved (CSJJI) females, or how to best provide screening for sexually transmitted infections in this population. A pilot intervention allowed case managers to offer optional CT/GC screening to CSJJI females during mandated visits. Anonymous satisfaction surveys and discussion groups assessed intervention acceptability. Case managers met with 514 CSJJI females; 102 (20%) agreed to screening and 117 tests were completed. Among those screened, 21 (18%) had CT and 3 (3%) had GC. Intervention feedback from case managers and clients was positive, but there were barriers to recruitment. Lessons learned from this case manager-facilitated intervention may increase the acceptability and effectiveness of future screening methods in this setting.
AghaizuA., AdamsE. J., TurnerK., KerryS., HayP., SimmsI., OakeshottP. (2011). What is the cost of pelvic inflammatory disease and how much could be prevented by screening for . chlamydia trachomatis? Cost analysis of the Prevention of Pelvic Infection (POPI) trial. Sexually Transmitted Infections, 87, 312–317.
2.
BelenkoS., DemboR., RollieM., ChildsK., SalvatoreC. (2009). Detecting, preventing, and treating sexually transmitted diseases among adolescent arrestees: An unmet public health need. American Journal of Public Health, 99, 1032–1041.
3.
BelenkoS., DemboR., WeilandD., RollieM., SalvatoreC., HanlonA., ChildsK. (2008). Recently arrested adolescents are at high risk for sexually transmitted diseases. Sexually Transmitted Diseases, 35, 758–763.
Centers for Disease Control and Prevention. (2009). Chlamydia screening among sexually active young female enrollees of health plans—United States, 2000-2007. MMWR: Morbidity and Mortality Weekly Report, 58, 362–365.
6.
Centers for Disease Control and Prevention. (2010a). Sexually Transmitted Disease Surveillance 2009. Retrieved from http://www.cdc.gov/std/stats09/
Centers for Disease Control and Prevention. (2011). CDC Grand Rounds: Chlamydia prevention: Challenges and strategies for reducing disease burden and sequelae. MMWR: Morbidity and Mortality Weekly Report, 60, 370–373.
9.
CromwellP. F., RisserW. L., RisserJ. M. (2002). Prevalence and incidence of pelvic inflammatory disease in incarcerated adolescents. Sexually Transmitted Diseases, 29, 391–396.
10.
CrosbyR. A., DiClementeR. J., WingoodG. M., RoseE., LevineD. (2003). Adjudication history and African American adolescents’ risk for acquiring sexually transmitted diseases: An exploratory analysis. Sexually Transmitted Diseases, 30, 634–638.
11.
DemboR., BelenkoS., ChildsK., WarehamJ. (2009). Drug use and sexually transmitted diseases among female and male arrested youths. Journal of Behavioral Medicine, 32, 129–141.
12.
FryeJ. C., WallaceL., ChavezR. S., LuceD. A. (2008). Screening and treatment guidelines for chlamydia trachomatis in incarcerated adolescents: A review. . Journal of Correctional Health Care, 14, 89–98.
13.
HammettT. M. (2009). Sexually transmitted diseases and incarceration. Current Opinion in Infectious Disease, 22, 77–81.
14.
HammettT. M., GaiterJ. L., CrawfordC. (1998). Reaching seriously at-risk populations: Health interventions in criminal justice settings. Health Education and Behavior, 25, 99–120.
15.
KahnR. H., MosureD. J., BlankS., KentC. K., ChowJ. M., BoudovM. R.…Jail STD Prevalence Monitoring Project. (2005). Chlamydia trachomatis and Neisseria gonorrhoeae prevalence and coinfection in adolescents entering selected U.S. juvenile detention centers, 1997-2002. Sexually Transmitted Diseases, 32, 255–259.
16.
KatzA. R., LeeM. V. C., OhyeR. G., EfflerP. V., JohnsonE. C., NishiS. M. (2004). Prevalence of chlamydial and gonorrheal infections among females in a juvenile detention facility, Honolulu, Hawaii. Journal of Community Health, 29, 265–269.
17.
LofyK. H., HofmannJ., MosureD. J., FineD. N., MarrazzoJ. M. (2006). Chlamydial infections among female adolescents screened in juvenile detention centers in Washington State, 1998-2002. Sexually Transmitted Diseases, 33, 63–67.
MertzK. J., VoigtR. A., HutchinsK., LevineW. C. & Jail STD Prevalence Monitoring Group. (2002). Findings from STD screening of adolescents and adults entering corrections facilities: Implications for STD control strategies. Sexually Transmitted Diseases, 29, 834–839.
20.
MorrisR. E., HarrisonE. A., KnoxG. W., TromanhauserE., MarquisD. K., WattsL. L. (1995). Health risk behavioral survey from 39 juvenile correctional facilities in the United States. Journal of Adolescent Health, 17, 334–344.
21.
RobertsonA. A., ThomasC. B., St. LawrenceJ. S, PackR. (2005). Predictors of infection with chlamydia or gonorrhea in incarcerated adolescents. Sexually Transmitted Diseases, 32, 115–122.
22.
RomeroE. G., TeplinL. A., McClellandG. M., AbramK. M., WeltyL. J., WashburnJ. J. (2007). A longitudinal study of the prevalence, development, and persistence of HIV/sexually transmitted infection risk behaviors in delinquent youth: Implications for health care in the community. Pediatrics, 119, e1126–1141.
23.
SpauldingA. C., ClarkeJ. G., JongcoA. M., FlaniganT. P. (2009). Small reservoirs: Jail screening for gonorrhea and chlamydia in low prevalence areas. Journal of Correctional Health Care, 15, 28–34.
24.
WoodV. D., ShoroyeA. (1993). Sexually transmitted disease among adolescents in the juvenile justice system of the District of Columbia. Journal of the National Medical Association, 85, 435–439.
